EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase I)VergleichsstudieOpen Access · CC BY 4.0

Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial

Jimena Coimbra, Montserrat Puntes, Pol Molina, Ignasi Gich, Rosa Antonijoan, Inmaculada Gilaberte, Paula Arranz, Carlos Sánchez

European Journal of Pharmaceutical Sciences · 2024-12 · 203 · 106900

DOI: 10.1016/j.ejps.2024.106900 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Pharmaceutical Sciences, 2024-12. Verfasst von Jimena Coimbra und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre d'Investigació de Medicaments (CIM), Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain. Hauptthemen laut MEDLINE: Chlorpheniramine, Benzimidazoles, Cross-Over Studies, Histamine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Government of the Basque Country.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChlorpheniramineBenzimidazolesCross-Over StudiesHistaminePiperidinesHumansMaleAdultFemaleDouble-Blind MethodAdministration, OralYoung AdultHistamine H1 AntagonistsMiddle AgedUrticaria

Stichwörter der Autor:innen

BilastineIntramuscularIntravenousPharmacodynamicsRhinoconjunctivitisUrticaria

Substanzen

bilastineChlorpheniramineBenzimidazolesHistaminedexchlorpheniraminePiperidinesHistamine H1 Antagonists

Autor:innen und Institutionen

  • Centre d'Investigació de Medicaments (CIM), Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.
  • CIBER Epidemiología y Salud Pública (CIBERESP), Spain, Clinical Epidemiology and Public Health Department, Hospital de la Santa Creu i Santa Pau, Barcelona, Spain, Universitat Autónoma de Barcelona (UAB), Bellaterra, Sp…
  • Clinical Pharmacology Department, Hospital de la Santa Creu i Sant Pau, Centre d'Investigació de Medicaments (CIM), Institut de Recerca Sant Pau (IR SANT PAU), Pharmacology and Therapeutics Department, Universitat Autón…
  • Medical Department, FAES FARMA S. A., Leioa (Vizcaya), Spain.
  • Medical Department, FAES FARMA S. A., Leioa (Vizcaya), Spain. Electronic address: csanchez@faes.es.

Förderung

  • Government of the Basque Country

Zitieren

APA

Coimbra, J., Puntes, M., Molina, P., Gich, I., Antonijoan, R., Gilaberte, I., Arranz, P., & Sánchez, C. (2024). Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial. European Journal of Pharmaceutical Sciences, 203, 106900. https://doi.org/10.1016/j.ejps.2024.106900

Vancouver

Coimbra J, Puntes M, Molina P, Gich I, Antonijoan R, Gilaberte I, et al. Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial. European Journal of Pharmaceutical Sciences. 2024;203:106900. doi:10.1016/j.ejps.2024.106900

BibTeX
@article{Coimbra2024,
  author = {Coimbra, Jimena and Puntes, Montserrat and Molina, Pol and Gich, Ignasi and Antonijoan, Rosa and Gilaberte, Inmaculada and Arranz, Paula and Sánchez, Carlos},
  title = {Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial},
  journal = {European Journal of Pharmaceutical Sciences},
  year = {2024},
  volume = {203},
  pages = {106900},
  doi = {10.1016/j.ejps.2024.106900}
}
Kostenlos starten →